MedTrace Logo

Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease

NCT01067963 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-06-09

No results posted yet for this study

Summary

The purpose of this study is to establish the usefulness and the impact of a tailored behavioral-education and counseling intervention titled Self-Management and Resourceful Transition (S.M.a.R.T) among patients with type 2 diabetes mellitus and stage 3 chronic kidney disease, in order to help them to manage their behaviors related to their condition and health.

Conditions

  • Diabetes Mellitus, Type 2
  • Renal Insufficiency, Chronic

Interventions

BEHAVIORAL

Computer assisted education and motivational interviewing.

9 study contact points. 3-week intervention using computer-assisted learning modules and telephone counseling using motivational interviewing.

BEHAVIORAL

Group talks/social chat

9 study contact points. 3 group talk session on general topics about healthy lifestyle, printed power point handouts, telephone calls comprised of social conversation to discuss the handout content.

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Teresa J. Sakraida, PhD, RN · University of Colorado Denver College of Nursing

  • Alkesh Jani, MD · University of Colorado Denver, School of Medicine and VA Eastern Colorado Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067963 on ClinicalTrials.gov